Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Simona Lattanzi, Eugen Trinka, Emilio Russo, et al.
Drugs (2023) Vol. 83, Iss. 15, pp. 1409-1424
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis
Renzo Guerrini, Catherine Chiron, Delphine Vandame, et al.
Epilepsia Open (2024) Vol. 9, Iss. 2, pp. 689-703
Open Access | Times Cited: 10
The safety and effectiveness of tDCS for epileptic patients： A systematic review and meta-analysis
Xiaofeng Ding, Mingyu Hu, Chi Wang, et al.
Complementary Therapies in Medicine (2025) Vol. 89, pp. 103142-103142
Open Access | Times Cited: 1
Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis
Jingyi Tong, Tingting Ji, Ting Liu, et al.
Epilepsy & Behavior (2024) Vol. 152, pp. 109653-109653
Closed Access | Times Cited: 6
Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network meta-analysis
Dujiang Xia, Peng Zhang, Yankun Chen, et al.
Seizure (2024) Vol. 117, pp. 90-97
Closed Access | Times Cited: 6
Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ9-THC through the 5-HT1A Receptor in the Neocortex of Mice
Yasaman Javadzadeh, Alexandra Santos, Mark S. Aquilino, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 466-466
Open Access | Times Cited: 6
Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practice
Elaine Wirrell, Lieven Lagae, Ingrid E. Scheffer, et al.
Epilepsia Open (2024) Vol. 9, Iss. 5, pp. 1643-1657
Open Access | Times Cited: 6
Additional Results from Two Randomized, Placebo-Controlled Trials of Stiripentol in Dravet Syndrome Highlight a Rapid Antiseizure Efficacy with Longer Seizure-Free Periods
Renzo Guerrini, Laurent Chancharme, B Serraz, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 869-884
Open Access | Times Cited: 4
USO DO CANABIDIOL EM SÍNDROME DE DRAVET PRÉ-EXISTENTE: UMA REVISÃO NARRATIVA
Carla Soraya Costa Maia, A. Silva, Luiz Eduardo Canton Santos, et al.
Revista Contemporânea (2025) Vol. 5, Iss. 2, pp. e7424-e7424
Closed Access
Oral health effects of non-combustible nicotine products: protocol for a systematic review and network meta-analysis
Giusy Rita Maria La Rosa, Cinzia Del Giovane, Eugenio Pedullà, et al.
Systematic Reviews (2025) Vol. 14, Iss. 1
Open Access
Efficacy, safety, and tolerability of soticlestat (TAK-935) as adjunctive therapy in pediatric patients with dravet syndrome and Lennox–Gastaut syndrome: a meta-analysis of 3 randomized controlled trials
Lanlan Zhang, Jean Nana, Chengzhong Wang
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lack of effectiveness and seizure worsening with cenobamate in pediatric patients with Dravet syndrome
Rita Cagigal, Celia Romero‐del‐Rincon, Ana Laura Fernández‐Perrone, et al.
Epilepsia (2025)
Closed Access
The Impact and Adherence of Ketogenic Dietary Therapies for Dravet syndrome: A systematic review and meta-analysis
Yan Li, Sisi Dai, Qingqing Deng, et al.
Seizure (2025) Vol. 130, pp. 16-24
Closed Access
Caregiver-reported non-seizure and seizure outcomes with cannabidiol and clobazam in patients aged ≥2 years with Lennox-Gastaut syndrome or Dravet syndrome: A subgroup analysis of the BECOME survey
Μ. Scott Perry, Tracy Dixon‐Salazar, Mary Anne Meskis, et al.
Seizure (2025) Vol. 130, pp. 32-40
Open Access
The latest advances in the pharmacological management of focal epilepsies in children: a narrative review
Sara Matricardi, Giovanna Scorrano, Giovanni Prezioso, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 4, pp. 371-381
Closed Access | Times Cited: 2
Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome
Osama Y. Muthaffar, Ahmed K. Bamaga, Anas S. Alyazidi, et al.
Translational Pediatrics (2024) Vol. 13, Iss. 4, pp. 584-595
Open Access | Times Cited: 2
Update on Cannabidiol in Drug-Resistant Epilepsy
Amrita Singh, Priyanka Madaan, Dipika Bansal
The Indian Journal of Pediatrics (2024) Vol. 92, Iss. 1, pp. 61-69
Closed Access | Times Cited: 2
A comprehensive review of evolving treatment strategies for Dravet syndrome: Insights from randomized trials, meta-analyses, real-world evidence, and emerging therapeutic approaches
Debopam Samanta
Epilepsy & Behavior (2024) Vol. 162, pp. 110171-110171
Closed Access | Times Cited: 2
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population
Karolina Daniłowska, Natalia Picheta, Dominika Żyła, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3567-3567
Open Access | Times Cited: 1
Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review
Aakash Mahesan, Gautam Kamila, Sheffali Gulati
Annals of Indian Academy of Neurology (2024)
Open Access | Times Cited: 1
Adverse events associated with Stiripentol in children aged 0–17 years: An analysis of a real-world pharmacovigilance database
Tianyu Chen, Qiying Chen, Yuezhen Zhang, et al.
Epilepsy & Behavior (2024) Vol. 161, pp. 110073-110073
Closed Access | Times Cited: 1
A comprehensive assessment of palmatine as anticonvulsant agent – In vivo and in silico studies
Dorota Nieoczym, Marta Marszałek‐Grabska, Radosław Szalak, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116234-116234
Open Access
Die neuen anfallsunterdrückenden Medikamente für das Kindes- und Jugendalter
Gerhard Kurlemann, Ruth Lehbrink, Henry Bosse
Monatsschrift Kinderheilkunde (2024) Vol. 172, Iss. 3, pp. 225-234
Closed Access
Uso terapêutico do canabidiol na Síndrome de Dravet: Uma revisão sistemática
Maria Luiza Luna Sampaio, Vitória de Siqueira Oliveira Nunes, Lucia Gabriella da Silva Fonseca, et al.
Research Society and Development (2024) Vol. 13, Iss. 4, pp. e9713445620-e9713445620
Open Access
How Has the Treatment of Polish Children with Dravet Syndrome Changed? Future Perspectives
A Zielińska, Urszula Skarżyńska, Paulina Górka-Skoczylas, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1249-1249
Open Access
Antiseizure medications
Mei T. Liu, Daniel Greer, Megan Maroney
Side effects of drugs annual (2024), pp. 69-111
Closed Access
Page 1 - Next Page

Scroll to top